FGF10_HUMAN
ID FGF10_HUMAN Reviewed; 208 AA.
AC O15520; C7FDY0; Q6FHR3; Q6FHT6; Q96P59;
DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1998, sequence version 1.
DT 03-AUG-2022, entry version 187.
DE RecName: Full=Fibroblast growth factor 10;
DE Short=FGF-10;
DE AltName: Full=Keratinocyte growth factor 2;
DE Flags: Precursor;
GN Name=FGF10;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Lung;
RX PubMed=9287324; DOI=10.1074/jbc.272.37.23191;
RA Emoto H., Tagashira S., Mattei M.-G., Yamasaki M., Hashimoto G.,
RA Katsumata T., Negoro T., Nakatsuka M., Birnbaum D., Coulier F., Itoh N.;
RT "Structure and expression of human fibroblast growth factor-10.";
RL J. Biol. Chem. 272:23191-23194(1997).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Lung;
RA Jimenez P.A., Gruber J.R., Liu B., Feng P., Florence C., Blunt A.,
RA Huddleston K.A., Teliska M., Alfonso P., Coleman T.A., Ornitz D.M.,
RA Dillon P.A., Duan R.D.;
RT "Cutaneous wound healing by keratinocyte growth factor 2.";
RL Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP NUCLEOTIDE SEQUENCE [MRNA].
RA Zhang Y., Zhang B., Zhou Y., Peng X., Yuan J., Qiang B.;
RL Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN [4]
RP NUCLEOTIDE SEQUENCE [MRNA].
RA Nakhla A.M., Hryb D.J., Kahn S.M., Romas N.A., Rosner W.;
RT "Expression of FGF10 in human prostate stromal cells.";
RL Submitted (JUL-2009) to the EMBL/GenBank/DDBJ databases.
RN [5]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA LaBaer J.;
RT "Cloning of human full open reading frames in Gateway(TM) system entry
RT vector (pDONR201).";
RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN [6]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG NIEHS SNPs program;
RL Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN [7]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA Hunkapiller M.W., Myers E.W., Venter J.C.;
RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN [8]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Brain;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [9]
RP INTERACTION WITH FGFBP1.
RX PubMed=15806171; DOI=10.1038/sj.onc.1208560;
RA Beer H.-D., Bittner M., Niklaus G., Munding C., Max N., Goppelt A.,
RA Werner S.;
RT "The fibroblast growth factor binding protein is a novel interaction
RT partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity:
RT implications for epithelial repair.";
RL Oncogene 24:5269-5277(2005).
RN [10]
RP INTERACTION WITH FGFR1 AND FGFR2, AND FUNCTION IN STIMULATION OF CELL
RP PROLIFERATION.
RX PubMed=16597617; DOI=10.1074/jbc.m601252200;
RA Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M.;
RT "Receptor specificity of the fibroblast growth factor family. The complete
RT mammalian FGF family.";
RL J. Biol. Chem. 281:15694-15700(2006).
RN [11]
RP REVIEW.
RX PubMed=20094046; DOI=10.1038/nrc2780;
RA Turner N., Grose R.;
RT "Fibroblast growth factor signalling: from development to cancer.";
RL Nat. Rev. Cancer 10:116-129(2010).
RN [12]
RP X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 69-208 IN COMPLEX WITH FGFR2.
RX PubMed=12591959; DOI=10.1073/pnas.0436500100;
RA Yeh B.K., Igarashi M., Eliseenkova A.V., Plotnikov A.N., Sher I., Ron D.,
RA Aaronson S.A., Mohammadi M.;
RT "Structural basis by which alternative splicing confers specificity in
RT fibroblast growth factor receptors.";
RL Proc. Natl. Acad. Sci. U.S.A. 100:2266-2271(2003).
RN [13]
RP INVOLVEMENT IN ALSG.
RX PubMed=15654336; DOI=10.1038/ng1507;
RA Entesarian M., Matsson H., Klar J., Bergendal B., Olson L., Arakaki R.,
RA Hayashi Y., Ohuchi H., Falahat B., Bolstad A.I., Jonsson R.,
RA Wahren-Herlenius M., Dahl N.;
RT "Mutations in the gene encoding fibroblast growth factor 10 are associated
RT with aplasia of lacrimal and salivary glands.";
RL Nat. Genet. 37:125-127(2005).
RN [14]
RP VARIANT LADDS ARG-156.
RX PubMed=16630169; DOI=10.1111/j.1399-0004.2006.00597.x;
RA Milunsky J.M., Zhao G., Maher T.A., Colby R., Everman D.B.;
RT "LADD syndrome is caused by FGF10 mutations.";
RL Clin. Genet. 69:349-354(2006).
RN [15]
RP VARIANT LADDS PHE-106.
RX PubMed=16501574; DOI=10.1038/ng1757;
RA Rohmann E., Brunner H.G., Kayserili H., Uyguner O., Nuernberg G., Lew E.D.,
RA Dobbie A., Eswarakumar V.P., Uzumcu A., Ulubil-Emeroglu M., Leroy J.G.,
RA Li Y., Becker C., Lehnerdt K., Cremers C.W.R.J., Yueksel-Apak M.,
RA Nuernberg P., Kubisch C., Schlessinger J., van Bokhoven H., Wollnik B.;
RT "Mutations in different components of FGF signaling in LADD syndrome.";
RL Nat. Genet. 38:414-417(2006).
CC -!- FUNCTION: Plays an important role in the regulation of embryonic
CC development, cell proliferation and cell differentiation. Required for
CC normal branching morphogenesis. May play a role in wound healing.
CC {ECO:0000269|PubMed:16597617}.
CC -!- SUBUNIT: Interacts with FGFR1 and FGFR2. Interacts with FGFBP1.
CC {ECO:0000269|PubMed:12591959, ECO:0000269|PubMed:15806171,
CC ECO:0000269|PubMed:16597617}.
CC -!- INTERACTION:
CC O15520; P21802: FGFR2; NbExp=2; IntAct=EBI-1035684, EBI-1028658;
CC O15520; Q8N9Q2: SREK1IP1; NbExp=3; IntAct=EBI-1035684, EBI-10268630;
CC O15520; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-1035684, EBI-741515;
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC -!- DISEASE: Aplasia of lacrimal and salivary glands (ALSG) [MIM:180920]: A
CC rare condition characterized by dry conjunctival mucosae, irritable
CC eyes, epiphora (constant tearing), and xerostomia (dryness of the
CC mouth), which increases risk of dental erosion, dental caries,
CC periodontal disease, and oral infections. ALSG has variable
CC expressivity, and affected individuals may have aplasia or hypoplasia
CC of the lacrimal, parotid, submandibular, and sublingual glands and
CC absence of the lacrimal puncta. {ECO:0000269|PubMed:15654336}. Note=The
CC disease is caused by variants affecting the gene represented in this
CC entry.
CC -!- DISEASE: Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730]:
CC An autosomal dominant ectodermal dysplasia, a heterogeneous group of
CC disorders due to abnormal development of two or more ectodermal
CC structures. Lacrimo-auriculo-dento-digital syndrome is characterized by
CC aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped
CC ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb
CC segments anomalies. In addition to these cardinal features, facial
CC dysmorphism, malformations of the kidney and respiratory system and
CC abnormal genitalia have been reported. Craniosynostosis and severe
CC syndactyly are not observed. {ECO:0000269|PubMed:16501574,
CC ECO:0000269|PubMed:16630169}. Note=The disease is caused by variants
CC affecting the gene represented in this entry.
CC -!- SIMILARITY: Belongs to the heparin-binding growth factors family.
CC {ECO:0000305}.
CC -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC URL="http://egp.gs.washington.edu/data/fgf10/";
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB002097; BAA22331.1; -; mRNA.
DR EMBL; U67918; AAB61991.1; -; mRNA.
DR EMBL; AF411527; AAL05875.1; -; mRNA.
DR EMBL; GQ351295; ACU00617.1; -; mRNA.
DR EMBL; CR541665; CAG46466.1; -; mRNA.
DR EMBL; CR541688; CAG46489.1; -; mRNA.
DR EMBL; AY604046; AAS99733.1; -; Genomic_DNA.
DR EMBL; CH471119; EAW56075.1; -; Genomic_DNA.
DR EMBL; BC069561; AAH69561.1; -; mRNA.
DR EMBL; BC105021; AAI05022.1; -; mRNA.
DR EMBL; BC105023; AAI05024.1; -; mRNA.
DR CCDS; CCDS3950.1; -.
DR RefSeq; NP_004456.1; NM_004465.1.
DR RefSeq; XP_005248321.1; XM_005248264.3.
DR PDB; 1NUN; X-ray; 2.90 A; A=64-208.
DR PDBsum; 1NUN; -.
DR AlphaFoldDB; O15520; -.
DR SMR; O15520; -.
DR BioGRID; 108546; 12.
DR DIP; DIP-6037N; -.
DR IntAct; O15520; 9.
DR STRING; 9606.ENSP00000264664; -.
DR GlyGen; O15520; 2 sites.
DR iPTMnet; O15520; -.
DR PhosphoSitePlus; O15520; -.
DR BioMuta; FGF10; -.
DR EPD; O15520; -.
DR MassIVE; O15520; -.
DR PaxDb; O15520; -.
DR PeptideAtlas; O15520; -.
DR PRIDE; O15520; -.
DR ProteomicsDB; 48721; -.
DR Antibodypedia; 4149; 424 antibodies from 37 providers.
DR DNASU; 2255; -.
DR Ensembl; ENST00000264664.5; ENSP00000264664.4; ENSG00000070193.5.
DR GeneID; 2255; -.
DR KEGG; hsa:2255; -.
DR MANE-Select; ENST00000264664.5; ENSP00000264664.4; NM_004465.2; NP_004456.1.
DR UCSC; uc003jog.2; human.
DR CTD; 2255; -.
DR DisGeNET; 2255; -.
DR GeneCards; FGF10; -.
DR HGNC; HGNC:3666; FGF10.
DR HPA; ENSG00000070193; Tissue enhanced (ovary).
DR MalaCards; FGF10; -.
DR MIM; 149730; phenotype.
DR MIM; 180920; phenotype.
DR MIM; 602115; gene.
DR neXtProt; NX_O15520; -.
DR OpenTargets; ENSG00000070193; -.
DR Orphanet; 86815; Aplasia of lacrimal and salivary glands.
DR Orphanet; 2363; Lacrimoauriculodentodigital syndrome.
DR PharmGKB; PA28106; -.
DR VEuPathDB; HostDB:ENSG00000070193; -.
DR eggNOG; KOG3885; Eukaryota.
DR GeneTree; ENSGT00940000158907; -.
DR HOGENOM; CLU_081609_3_1_1; -.
DR InParanoid; O15520; -.
DR OMA; KWILTHG; -.
DR OrthoDB; 1340221at2759; -.
DR PhylomeDB; O15520; -.
DR TreeFam; TF317805; -.
DR PathwayCommons; O15520; -.
DR Reactome; R-HSA-109704; PI3K Cascade.
DR Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR Reactome; R-HSA-190370; FGFR1b ligand binding and activation.
DR Reactome; R-HSA-190377; FGFR2b ligand binding and activation.
DR Reactome; R-HSA-2033519; Activated point mutants of FGFR2.
DR Reactome; R-HSA-210747; Regulation of gene expression in early pancreatic precursor cells.
DR Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR Reactome; R-HSA-5654219; Phospholipase C-mediated cascade: FGFR1.
DR Reactome; R-HSA-5654221; Phospholipase C-mediated cascade, FGFR2.
DR Reactome; R-HSA-5654687; Downstream signaling of activated FGFR1.
DR Reactome; R-HSA-5654688; SHC-mediated cascade:FGFR1.
DR Reactome; R-HSA-5654689; PI-3K cascade:FGFR1.
DR Reactome; R-HSA-5654693; FRS-mediated FGFR1 signaling.
DR Reactome; R-HSA-5654695; PI-3K cascade:FGFR2.
DR Reactome; R-HSA-5654699; SHC-mediated cascade:FGFR2.
DR Reactome; R-HSA-5654700; FRS-mediated FGFR2 signaling.
DR Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
DR Reactome; R-HSA-5655253; Signaling by FGFR2 in disease.
DR Reactome; R-HSA-5658623; FGFRL1 modulation of FGFR1 signaling.
DR Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR SignaLink; O15520; -.
DR SIGNOR; O15520; -.
DR BioGRID-ORCS; 2255; 241 hits in 1072 CRISPR screens.
DR ChiTaRS; FGF10; human.
DR EvolutionaryTrace; O15520; -.
DR GeneWiki; FGF10; -.
DR GenomeRNAi; 2255; -.
DR Pharos; O15520; Tbio.
DR PRO; PR:O15520; -.
DR Proteomes; UP000005640; Chromosome 5.
DR RNAct; O15520; protein.
DR Bgee; ENSG00000070193; Expressed in buccal mucosa cell and 115 other tissues.
DR ExpressionAtlas; O15520; baseline and differential.
DR Genevisible; O15520; HS.
DR GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR GO; GO:0042056; F:chemoattractant activity; IDA:UniProtKB.
DR GO; GO:0005104; F:fibroblast growth factor receptor binding; IDA:UniProtKB.
DR GO; GO:0008083; F:growth factor activity; IDA:UniProtKB.
DR GO; GO:0008201; F:heparin binding; IDA:UniProtKB.
DR GO; GO:0005111; F:type 2 fibroblast growth factor receptor binding; IPI:UniProtKB.
DR GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
DR GO; GO:0060667; P:branch elongation involved in salivary gland morphogenesis; IEA:Ensembl.
DR GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB.
DR GO; GO:0060436; P:bronchiole morphogenesis; IEA:Ensembl.
DR GO; GO:0060449; P:bud elongation involved in lung branching; IEA:Ensembl.
DR GO; GO:0060447; P:bud outgrowth involved in lung branching; IDA:MGI.
DR GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl.
DR GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
DR GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
DR GO; GO:0030538; P:embryonic genitalia morphogenesis; IEA:Ensembl.
DR GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR GO; GO:0001935; P:endothelial cell proliferation; IEA:Ensembl.
DR GO; GO:0050673; P:epithelial cell proliferation; IDA:UniProtKB.
DR GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl.
DR GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB.
DR GO; GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl.
DR GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR GO; GO:0048807; P:female genitalia morphogenesis; IEA:Ensembl.
DR GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IBA:GO_Central.
DR GO; GO:0060595; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; IDA:MGI.
DR GO; GO:0048144; P:fibroblast proliferation; IEA:Ensembl.
DR GO; GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl.
DR GO; GO:0070384; P:Harderian gland development; IEA:Ensembl.
DR GO; GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl.
DR GO; GO:0043616; P:keratinocyte proliferation; IEA:Ensembl.
DR GO; GO:0032808; P:lacrimal gland development; IMP:UniProtKB.
DR GO; GO:0060174; P:limb bud formation; IEA:Ensembl.
DR GO; GO:0060173; P:limb development; IBA:GO_Central.
DR GO; GO:0060428; P:lung epithelium development; IDA:MGI.
DR GO; GO:0061115; P:lung proximal/distal axis specification; IEA:Ensembl.
DR GO; GO:0060430; P:lung saccule development; IMP:UniProtKB.
DR GO; GO:0048808; P:male genitalia morphogenesis; IEA:Ensembl.
DR GO; GO:0060615; P:mammary gland bud formation; IEA:Ensembl.
DR GO; GO:0060915; P:mesenchymal cell differentiation involved in lung development; IEA:Ensembl.
DR GO; GO:0060496; P:mesenchymal-epithelial cell signaling involved in lung development; IEA:Ensembl.
DR GO; GO:0001823; P:mesonephros development; IEP:UniProtKB.
DR GO; GO:0001656; P:metanephros development; IEP:UniProtKB.
DR GO; GO:0003338; P:metanephros morphogenesis; IEA:Ensembl.
DR GO; GO:0042693; P:muscle cell fate commitment; IEA:Ensembl.
DR GO; GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl.
DR GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR GO; GO:2000647; P:negative regulation of stem cell proliferation; IEA:Ensembl.
DR GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR GO; GO:0001759; P:organ induction; IEA:Ensembl.
DR GO; GO:0030916; P:otic vesicle formation; IEA:Ensembl.
DR GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR GO; GO:0050918; P:positive chemotaxis; IDA:UniProtKB.
DR GO; GO:0032781; P:positive regulation of ATP-dependent activity; IDA:UniProtKB.
DR GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central.
DR GO; GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB.
DR GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl.
DR GO; GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProtKB.
DR GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB.
DR GO; GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; NAS:UniProtKB.
DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IBA:GO_Central.
DR GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB.
DR GO; GO:0010628; P:positive regulation of gene expression; IBA:GO_Central.
DR GO; GO:0071338; P:positive regulation of hair follicle cell proliferation; IDA:UniProtKB.
DR GO; GO:0051549; P:positive regulation of keratinocyte migration; IDA:UniProtKB.
DR GO; GO:0010838; P:positive regulation of keratinocyte proliferation; IDA:UniProtKB.
DR GO; GO:0050671; P:positive regulation of lymphocyte proliferation; IDA:UniProtKB.
DR GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB.
DR GO; GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl.
DR GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR GO; GO:0001934; P:positive regulation of protein phosphorylation; IBA:GO_Central.
DR GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB.
DR GO; GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl.
DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR GO; GO:0050677; P:positive regulation of urothelial cell proliferation; IDA:UniProtKB.
DR GO; GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl.
DR GO; GO:0070352; P:positive regulation of white fat cell proliferation; IEA:Ensembl.
DR GO; GO:0060513; P:prostatic bud formation; IEA:Ensembl.
DR GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
DR GO; GO:0060019; P:radial glial cell differentiation; ISS:UniProtKB.
DR GO; GO:0032925; P:regulation of activin receptor signaling pathway; IEA:Ensembl.
DR GO; GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IEA:Ensembl.
DR GO; GO:0030334; P:regulation of cell migration; IBA:GO_Central.
DR GO; GO:0046877; P:regulation of saliva secretion; IMP:UniProtKB.
DR GO; GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl.
DR GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR GO; GO:0007431; P:salivary gland development; IMP:UniProtKB.
DR GO; GO:0061033; P:secretion by lung epithelial cell involved in lung growth; IDA:UniProtKB.
DR GO; GO:0060879; P:semicircular canal fusion; IEA:Ensembl.
DR GO; GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl.
DR GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR GO; GO:0072089; P:stem cell proliferation; IEA:Ensembl.
DR GO; GO:0060661; P:submandibular salivary gland formation; IEA:Ensembl.
DR GO; GO:0070075; P:tear secretion; IMP:UniProtKB.
DR GO; GO:0048538; P:thymus development; IDA:UniProtKB.
DR GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR GO; GO:0042246; P:tissue regeneration; IEA:Ensembl.
DR GO; GO:0060510; P:type II pneumocyte differentiation; IEA:Ensembl.
DR GO; GO:0050674; P:urothelial cell proliferation; IDA:UniProtKB.
DR GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl.
DR GO; GO:0050872; P:white fat cell differentiation; IEA:Ensembl.
DR GO; GO:0070343; P:white fat cell proliferation; IEA:Ensembl.
DR GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR GO; GO:0042060; P:wound healing; IDA:UniProtKB.
DR CDD; cd00058; FGF; 1.
DR IDEAL; IID00527; -.
DR InterPro; IPR028252; FGF10.
DR InterPro; IPR002209; Fibroblast_GF_fam.
DR InterPro; IPR008996; IL1/FGF.
DR PANTHER; PTHR11486; PTHR11486; 1.
DR PANTHER; PTHR11486:SF21; PTHR11486:SF21; 1.
DR Pfam; PF00167; FGF; 1.
DR PRINTS; PR00263; HBGFFGF.
DR SMART; SM00442; FGF; 1.
DR SUPFAM; SSF50353; SSF50353; 1.
DR PROSITE; PS00247; HBGF_FGF; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Disease variant; Ectodermal dysplasia; Glycoprotein;
KW Growth factor; Lacrimo-auriculo-dento-digital syndrome; Reference proteome;
KW Secreted; Signal.
FT SIGNAL 1..37
FT /evidence="ECO:0000255"
FT CHAIN 38..208
FT /note="Fibroblast growth factor 10"
FT /id="PRO_0000008981"
FT CARBOHYD 51
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 196
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT VARIANT 106
FT /note="C -> F (in LADDS; dbSNP:rs104893885)"
FT /evidence="ECO:0000269|PubMed:16501574"
FT /id="VAR_029888"
FT VARIANT 156
FT /note="I -> R (in LADDS; dbSNP:rs104893886)"
FT /evidence="ECO:0000269|PubMed:16630169"
FT /id="VAR_029889"
FT CONFLICT 43
FT /note="D -> V (in Ref. 5; CAG46489)"
FT /evidence="ECO:0000305"
FT CONFLICT 120
FT /note="V -> A (in Ref. 3; AAL05875)"
FT /evidence="ECO:0000305"
FT CONFLICT 134
FT /note="M -> R (in Ref. 3; AAL05875)"
FT /evidence="ECO:0000305"
FT HELIX 70..73
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 76..84
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 89..92
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 98..101
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 111..117
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 120..125
FT /evidence="ECO:0007829|PDB:1NUN"
FT TURN 126..129
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 130..134
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 138..145
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 150..156
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 162..171
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 174..177
FT /evidence="ECO:0007829|PDB:1NUN"
FT HELIX 189..191
FT /evidence="ECO:0007829|PDB:1NUN"
FT HELIX 197..199
FT /evidence="ECO:0007829|PDB:1NUN"
FT STRAND 201..205
FT /evidence="ECO:0007829|PDB:1NUN"
SQ SEQUENCE 208 AA; 23436 MW; C0A0705C108680B3 CRC64;
MWKWILTHCA SAFPHLPGCC CCCFLLLFLV SSVPVTCQAL GQDMVSPEAT NSSSSSFSSP
SSAGRHVRSY NHLQGDVRWR KLFSFTKYFL KIEKNGKVSG TKKENCPYSI LEITSVEIGV
VAVKAINSNY YLAMNKKGKL YGSKEFNNDC KLKERIEENG YNTYASFNWQ HNGRQMYVAL
NGKGAPRRGQ KTRRKNTSAH FLPMVVHS
